Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical 3% Diclofenac Nano-Emulsion for Knee Osteoarthritis
NCT00484120Phase 2Completed
- Sponsor
- Pharmos Corporation
- Start
- Jun 2007
- Primary completion
- Nov 2008
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of diclofenac in osteoarthritis (OA), sponsored by Pharmos Corporation. Started Jun 2007; status: completed.
02
Drugs
diclofenac
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00484120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00484120.